Molecular Biology Cell
Vol. 8, 205-217, February 1997


SEC31 Encodes Essential Component COPII
Coat Required Transport Vesicle Budding Endoplasmic Reticulum
Nina R. Salama,t John S. Chuang, Randy W. Schekman*
Department Molecular Cell Biology, Howard Hughes Research Institute, University California, Berkeley, California 94720
Submitted July 1, 1996; Accepted October 23, 1996
Monitoring Editor: Suzanne R. Pfeffer


        COPII vesicle coat protein promotes formation endoplasmic reticulum- (ER)
        derived transport vesicles carry secretory proteins Golgi complex Saccha-
        romyces cerevisiae. coat protein consists Sarlp, Sec23p protein complex 
        taining Sec23p Sec24p, Secl3p protein complex containing Secl3p         novel 150-kDa protein, p150.  report cloning characterization p150
        gene. p150 encoded essential gene. Depletion protein vivo blocks         exit secretory proteins ER causes elaboration ER membranes,
        indicating p150 encoded SEC gene. Additionally, overproduction p150
        gene product compromises growth ER Golgi sec mutants: secl6-2         sec23-1. p150 encoded SEC31, gene isolated genetic screen mutations         accumulate unprocessed forms secretory protein factor. sec31-1 mutation
        mapped gap repair, sequence analysis revealed alanine valine change
        position 1239, near carboxyl terminus. Sec3lp phosphoprotein treatment
        Sec31p-containing fraction alkaline phosphatase results 50-75  inhibi-
        tion transport vesicle formation activity ER membrane budding assay.

INTRODUCTION                                                    secretory pathway bidirectional. Mor- maturation secretory proteins requires transit           phological analysis pulse-radiolabeled secretory organelles secretory pathway. Se-            proteins vivo established transport cretory proteins start journey endoplasmic         compartments secretory pathway utilizes vesi-
reticulum (ER) receive asparagine-linked             cle carriers (Palade, 1975). considerable core oligosaccharide modifications. travel            attention focused vesicle formation Golgi complex elaboration              transport step secretory pathway, N-linked carbohydrate moiety additional modifi-             ER Golgi. proteinaceous coats function cation sulfonation, 0-linked glycosylation,          drive vesicle formation pathway:
phosphorylation occur. Finally, delivered          COPI COPII (Orci et al., 1993; Barlowe et al., 1994, plasma membrane secretory vesicles          Bednarak et al., 1995). lysosome (called vacuole yeast) cycling              COPI, originally isolated coat protein trans- endosomes. Resident proteins various se-             port vesicles carrying secretory proteins cretory pathway organelles reach final destina-           cis medial compartments Golgi complex,
tion retention appropriate organelle        contains seven polypeptides  c) small GTP
retrieval later compartments.  travel                 binding protein Arf (Malhotra et al., 1989; Serafini et
                                                                al., 1991a,b). Large scale purification coatomer,   * Corresponding author.
                                                                cytosolic assembly unit COPI, allowed mo-
  tCurrent   address: Department Microbiology Immunol-   lecular analysis COPI subunits (Waters
    ogy, Stanford University School Medicine, Stanford, CA   et al., 1991). COPI functions restricted intra-
    94305-5402.                                                 Golgi transport. Yeast mutants COPI sub-

© 1997 American Society Cell Biology                                                                        205
 N.R. Salama et al.

units properly retain ER resident transmem-          Sec24p vivo causes block ER Golgi transport
brane proteins bearing di-lysine retrieval signal         (Yoshihisa et al., unpublished data). context (Letourneur et al., 1994). Additionally, mamma-        ER membrane, Sec24p prevent Sec23p lian yeast COPI directly bind di-lysine moiety        interacting Sarlp vesicle formation fused glutathione S-transferase (Cosson Letour-      finished, impeding Sarlp-GTP hydrolysis neur, 1994).  COPI direct sorting           premature uncoating nascent vesicle. Finally,
proteins bearing di-lysine retention signal        Secl3p complex recruited mem-
retrograde transport vesicles traveling Golgi      brane complete COPII assembly. SEC13 encodes ER. Antibodies directed ,B subunit    33-kDa hydrophilic protein containing WD repeat
COPI cause accumulation secretory proteins        motifs make bulk coding sequence.
ER vivo vitro, pointing additional          WD repeat, identified X3 subunit requirement COPI function anterograde trans-         heterotrimeric G proteins, located num-
port ER Golgi (Pepperkok et al., 1993;      ber proteins diverse functions, including tran-
Peter et al., 1993).                                        scriptional activation, RNA splicing, spindle pole
   yeast Saccharomyces cerevisiae, approach       body assembly (Neer et al., 1994). common fea-
combining genetic analysis mutants defective         ture proteins participation multi-
secretion vivo biochemical analysis         protein complexes. Biochemical characterization reaction reconstituting protein transport       Secl3p revealed ability promote vesicle
ER Golgi vitro revealed set proteins    formation ER requires associated 150-kDa
required vesicle formation distinct COPI.          protein, p150 (Salama et al., 1993). proteins, addition biochemically          report cloning biochemical char-
quired vesicle formation ER, actually coat     acterization p150, called Sec31p. Like genes transport vesicles formed (Barlowe et al., 1994),       encoding COPII subunits, SEC31 encodes term COPII. COPII consists subunits        essential protein required ER-derived transport
(Sec23p, Sec24p, Secl3p, p150) small GTP-       vesicle formation vivo vitro. binding protein Sarlp (Barlowe et al., 1994).               sequence SEC31 does clues specific
   COPII does form cytosolic complex like             biochemical activity vesicle formation, char-
coatomer, instead forms context          acteristics regulator budding.
vesicle formation. Sarlp recruited membrane Secl2 protein (d'Enfert et al., 1991). SEC12   MATERIALS METHODS
encodes ER resident transmembrane glycoprotein
required transport vesicle formation vivo     Strains, Materials, General Methods
vitro (Nakano et al., 1988; Rexach Schekman,            Yeast strains used study RSY255 (leu2-3,112, ura 3-52,
1991). cytosolic domain Secl2p stimulates        MATa; D. Botstein), RSY256 (his4-619, leu2-3,112, MATa; D. Bot-
exchange GDP GTP Sarlp (Barlowe               stein), RSY267 (secl6-2, ura3-52, his4-619), RSY281 (sec23-1, ura3-
Schekman, 1993). activated form Sarlp initiates     52, his4-619), RSY368 (his3-11,15, leu2-3,112, ura3-1, ade2-1, trpl-1,
                                                            MATa), RSY612 (his3-11,15/his3-11,15, leu2-3,112/leu2-3,112, ura3-
recruitment cytosolic complexes: Sec23p/         l/ura3-1, ade2-1/ade2-1, trpl-lltrpl-1, MATa/MATa), RSY1002
Sec24p complex Secl3p/p150 complex. SEC23           (sec31::TRP1/SEC31, his3-11,15/his3-11,15, leu2-3,112/leu2-3,112,
encodes 85-kDa protein stimulates Sarlp-GTP         ura3-1/ura3-1, ade2-1/ade2-1, trpl-1Itrpl-1, MATa/MATa), RSY1003
hydrolysis Sarlp-GDP (Yoshihisa et al., 1993).    (sec31::LEU2/SEC31, his3-11,15/his3-11,15, leu2-3,112/leu2-3,112,
presence nonhydrolyzable analogue, GMP-PNP,            ura3-1/ura3-1, ade2-1/ade2-1, trpl-1Itrpl-1, MATa/MATa), RSY1004
                                                            (sec31-1, ura3-52, leu2-3,112, MATa), RSY1076 (pHZ134 (GALl: source guanine nucleotide, vesicles form        p150, LEU2, ARS1, CEN4) sec3l::TRP1, his3-11,15, leu2-3,112, ura3-1, deliver contents Golgi complex          ade2-1, trpl-1, MATa). Plasmid pNS3141 subcloning
(Barlowe et al., 1994). conditions, COPII       SEC31 BamHI-EcoRI fragment pNS3132 described appears tightly associated vesicles     pCK1313 (SEC13, URA3, 2,u).
                                                              Yeast extract peptone growth medium contained 2  bacto-pep- reactions performed GTP. indicates        tone (Difco, Detroit, MI), 1  yeast extract (Difco), 2  glucose Sarlp GTP hydrolysis precedes disassembly           (YPD) 2  galactose (YPG). Minimal medium composed coat vesicle release uncoating precedes       1.67 g/l yeast nitrogen base amino acids ammonium
fusion Golgi membrane (Barlowe et al., 1994).      sulfate (Difco), 2  glucose, 2  galactose, supplemented SEC24 encodes 105-kDa protein known ho-           100 ,uM (NH4)2SO4 amino acids appropriate. Acetate
                                                            sporulation medium contained 1  potassium acetate 2  agar.
mologies biochemical activities (Yoshihisa et al.,       Liquid cultures grown vigorous agitation 30°C unpublished data). Sec24p does affect Sec23p            200-1 New Brunswick fermenter. Yeast genetic manipulations GTPase-activating protein activity solution,      molecular techniques described (Sambrook et al., 1989;
absolutely required vesicle formation vivo       Guthrie Fink, 1991). vitro (Hicke et al., 1992); excess monomeric Sec23p        Concanavalin Sepharose, protein Sepharose CL-4B, bulk Su-
                                                            perose 6, prepackaged Superose 6 column, standards replace Sec23p/Sec24p complex require-           calibration gel filtration columns purchased Phar-
ment vesicle formation vitro, depletion       macia (Piscataway, NJ). Molecular biology enzymes including Taq


206                                                                                                Molecular Biology Cell
                                                                                                                      SEC31 Characterization

DNA polymerase, Klenow DNA polymerase, T4 DNA ligase,                   proximately 100 bp SEC31 sequences 5' 600 bp 3' TRP1
polynucleotide kinase, restriction endonucleases pur-          gene (pNS3101) LEU2 gene (pNS3102). fragments chased Boehringer Mannheim (Indianapolis, .           gel purified using Geneclean (BIO 101) according manufac-
reagents purchased Sigma (St. Louis, MO)         turer's instructions. wild-type diploid yeast strain RSY612 different vendor indicated.                                        transformed HindIII fragment pNS3101 sec3l-
   Protein assays performed 1-20 ,ul samples micro-      1/SEC31 heterozygous diploid (RSY1004 x RSY256) trans-
titer plate using protein assay reagent (Bio-Rad, Richmond, CA).        formed HindIII fragment pNS3102 using lithium
Bovine serum albumin (BSA) used protein standard. Gel          acetate method (Ausubel et al., 1987). Transformants selected
electrophoresis performed according Laemmli (1970)           minimal medium lacking tryptophan, yielding RSY1002, lack-
SDS-PAGE method using 10  7.5  acrylamide. Electrophoresed           ing leucine, yielding JCY218. Transformants induced sporu-
proteins visualized silver staining (Hicke et al., 1992).   late acetate sporulation medium, meiotic products immunoblotting, electrophoresed proteins transferred ni-        separated phenotypic analysis micromanipulation. gener-
trocellulose filters (Schleicher & Schuell, Keene, NH) previously    ate pNS3101 pNS3102, pNS3132 digested KpnI described (Towbin et al., 1979). Filters blocked antibody      Sall cut uniquely bp 78 3522, respectively, p150. incubations performed 2  nonfat dry milk 20 mM             intervening coding sequence replaced KpnI-SalI
Tris-HCl (pH 7.4) 150 mM NaCl (TBS) 0.05  Tween 20             TRP1 fragment pJJ248 SmaI-SalI LEU2 fragment (Bio-Rad). Detection filter-bound antibodies performed using     pJJ250 (Jones Prakash, 1990). pNS3132 generated sub- enhanced chemiluminescence detection (Amersham, Ar-          cloning 5-kb HindIll fragment genomic clone containing
lington Heights,  1251I-labeled protein (ICN, Irvine, CA;       p150 HindlIl site YEp352k. construct YEp352k, Harlow Lane, 1988). Affinity-purified anti-Secl3p antibodies        KpnI site polylinker YEp352 (URA3, 2 p.; Hill et al., 1986) anti-Sec3lp antisera used 1:1000 dilution (Salama et      inactivated digesting KpnI, filling resulting 5'
al., 1993).                                                             overhang using Klenow DNA polymerase deoxyribonucleoside
                                                                        triphosphates religating newly generated blunt ends.
Cloning p150 clone gene encoding 150-kDa subunit purified
Secl3-dhfrp/pl5O complex, Secl3p complex dissociated         Pulse-Chase Analysis Carboxypeptidase Y (CPY)
2 M urea. Briefly, 1 ml (0.7 mg) purified Secl3-dhfrp/pl50       monitor secretion phenotype RSY1076 (pHZ134 (ARS4,
complex (Salama et al., 1993) diluted 1:1 2x urea buffer (4 M    CEN1, GAL1:p150 LEU2) pl50::TRP1), cells grown 0.2 OD6,0
urea, 0.4 M NaCl, 0.25 M Tris-HCl, pH 7.5). material           units/ml minimal medium 100 ,uM (NH4)2SO4 2 
loaded 104-ml Superose 6 column equilibrated urea buffer      galactose, collected resuspended minimal medium
using Pharmacia FPLC  Fractions (2 ml) collected      100 p.M (NH4)2SO4 2  glucose. initiate labeling, analyzed SDS-PAGE. aliquot (1 ml) peak fraction            collected resuspended cells minimal medium 2  glu-
containing p150 (fraction 31) adjusted 5 mM dithiothreitol heated 65°C 5 min. aliquot (100 ,ul) material     cose lacking sulfate 10 min adding 30 p.Ci/OD160 unit cells removed N-terminal sequence analysis fractionated        35S express label mix (New England Nuclear). Cells labeled 10  SDS-polyacrylamide gels followed transfer Immobilin-P         5 min 30°C, 0.01 volume chase cocktail (0.3  cysteine,
polyvinylidene difluoride membranes (Millipore, Bedford, MA).           0.4  methionine, 100 mM (NH4)2SO4) added. Labeling remainder brought 10 mM iodoacetimide incubated          terminated addition equal volume 20 mM NaN3 20 min 25°C. Dithiothreitol added 10 mM           incubation 5 min ice. Cells washed 0.5 ml fraction proteolyzed 100 ng LysC LysC trypsin        20 mM NaN3 resuspended 200 p.l TBS 0.1 
(Boehringer Mannheim, Mannheim, Germany) 100 mM                      Triton X-100 0.5 mM phenylmethylsulfonyl fluoride (PMSF).
NH4(CO3)2 purified reverse-phase high-pressure liquid            material transferred Eppendorf tube, SDS added
chromatography 300A C8 column (Vydac, Hesperia, CA).               1  final concentration, acid-washed glass beads (0.5 mm Peptides sequenced standard chemistry using fast cycles      diameter) added meniscus. cells lysed protein peptide 477A sequencer (2.1 x 150 mm, Applied Biosys-         vortexing 90 s maximal speed, sample heated tems, Foster City, CA). portion gene amplified        95°C 5 min. material transferred fresh Eppendorf
genomic yeast DNA  generous gift David Feldheim,            tube 800 ,lI TBS 0.5 mM PMSF added. resulting
laboratory) polymerase chain reaction (PCR) Perkin Elmer-       fraction contained 5 OD60, units cell equivalent/ml 1 x 10
Cetus thermocycler using degenerate oligonucleotides N4 (5'-GT-         cpm/ml. Nonspecific protein aggregates removed adding
NAARYTNGCNGARTTYTC-3') 149C (5'-TCNGCNSWYTC-                        25 p.l 10  IgGsorb  Enzyme Center, Malden, MA) 137 mM
NGGRTTCCA-3') corresponding N-terminal peptide                   NaCl, 2.7 mM KCI, 4.3 mM Na2HPO4-7H2O 1.4 mM KH2PO4
VKLAEFSRTA intemal peptide DNTVLLWNPESAE-                       (phosphate-buffered saline), mixing, centrifuging 2 min QLSQFP, respectively. PCR product gel-purified using            13,000 x g microcentrifuge (Tomy, Seiko, Tokyo, Japan). Ap-
Geneclean (BIO 101, Vista, CA), end-labeled reaction       proximately 1 x 107 cpm (100 ,ul) mixed 2 p.l anti-CPY
polynucleotide kinase [y-32PIATP (3000 Ci/mmol, New              antiserum (Stevens et al., 1982) 25 ,ul 10  protein Sepha-
gland Nuclear, Boston, MA). gene cloned screening          rose CL-4B 1 ml immunoprecipitation buffer (150 mM NaCl,
YEp24-based library (10-kb average insert) labeled PCR         1  Triton X-100, 0.1  SDS, 15 mM Tris-HCl, pH 7.5,2 mM NaN3)
product using standard techniques (Ausubel et al., 1987). single      8 h rotation 4°C. Immune complexes collected clone identified hybridized strongly probe iso-      centrifugation 30 s 13,000 x g, washed twice 1 ml lated plasmid DNA. DNA sequence insert deter-            immunoprecipitation buffer, 1 ml 2 M urea, 200 mM
mined using standard methods Sequenase (United States Bio-         NaCl, 1  Triton X-100, 100 mM Tris-HCl (pH 7.5), 2 mM NaN3,
chemical, Cleveland, OH) according manufacturer's                1 ml 500 mM NaCl, 1  Triton X-100, 20 mM Tris-HCl
instructions.                                                           (pH 7.5), 2 mM NaN3, 1 ml 50 mM NaCl, 10
                                                                        mM Tris-HCl (pH 7.5), 2 mM NaN3. washed precipitates
                                                                        resuspended 15 ,ul 2x SDS-polyacrylamide gel sample
Disruption p150                                                      buffer, heated 5 min 95°C, analyzed SDS-PAGE, null alleles p150 generated vitro digestion        visualized PhosphorImager (Molecular Dynamics, Menlo
pNS3101 pNS3102 HindlIl, giving fragment ap-            Park, CA).

Vol. 8, February 1997                                                                                                                        207
 N.R. Salama et al.

Preparation Temperature-shifted                                       phosphate (8500-9120 Ci/mmol, New England Nuclear)                                                                          added. Labeling terminated 60 min addition Cytosolic Extracts                                                       equal volume (3 ml) 20 mM NaN3 incubation 5 min ice.
RSY255 (SEC31) RSY1004 (sec31-1) grown 1 OD600 unit          Cells washed 5 ml 20 mM NaN3 cells/ml vigorous agitation. cultures transferred    resuspended 200 Al TBS 0.1  Triton X-100 0.5 mM
38°C 1 h harvested centrifugation 10 min          PMSF. material transferred Eppendorf tube, SDS 4000 x g GSA rotor (Sorvall, DuPont, Wilmington, . cell      added 1  final concentration, acid-washed glass beads (0.5
pellet washed B88 (20 mM N-2-hydroxyethylpipera-           mm diameter) added meniscus. samples zine-N'-2-ethanesulfonic acid-KOH, pH 6.8, 0.15 M KOAc, 250 mM           lysed vortexing 90 s maximum speed multivortexer
sorbitol, 5 mM MgOAc) resuspended 1000 OD600 units           (Tomy Seiko) heated 95°C 5 min. material cells/ml B88 0.5 mM PMSF lysed addition            transferred fresh Eppendorf tube 800 ,ul TBS 0.5 mM
equal volume acid-washed glass beads (0.5 mm diameter)         PMSF added, resulting fraction containing 5 OD600 units
vortexing twice 90 s maximal speed. resulting lysate      cell equivalent/ml 3 x 107 cpm/ml. Nonspecific protein aggre-
clarified centrifugation 5 min 5000 rpm Tomy refrig-      gates removed adding 25 Al 10  protein Sepharose
erated microcentrifuge (Tomy, Seiko) 30 min              CL-4B B88 2  BSA, mixing, centrifuging 2 min 100,000 x g TLA100.3 rotor (Beckman Instruments, Palo Alto,         13,000 x g microcentrifuge. Approximately 3 x 107 cpm (1 ml)
CA).                                                                     mixed 2 Al anti-Sec3lp antiserum (Salama et al., 1993),
                                                                         2 ,lI preimmune serum, 25 1,u 10  protein Sepharose
Sequencing sec31-1                                                    CL-4B B88 2  BSA followed incubation 8 h                                                                          rotation 4°C. Immune complexes collected 
Gap repair used map location sec31-1 mutation.
pNS3132 (SEC31, URA3, 2 ,u) digested KpnI SpeI, SalI SpeI, XhoI remove SEC31 sequences indicated Figure      Phosphoamino Acid Analysis Sec3lp
2. linearized gapped plasmids gel purified trans-
formed RSY1004 (sec31-1) using method Elble (1992).          Phosphoamino acid analysis performed immunoprecipi-
Transformants selected minimal medium lacking uracil             tated Sec3lp. Sec3Ip immunoprecipitated RSY255 cells
plated 25°C 38°C checked growth. Transformants            labeled [32Plinorganic phosphate described  Immune
missing sequences XhoI sites unable grow         complexes resolved 7.5  SDS-polyacrylamide gels. 38°C, cells transformed gapped             PhosphorImager cassette (Molecular Dynamics) exposed 2 h
plasmids grew 38°C. indicated mutation lay         gel wrapped Saran Wrap (Dow, Pittsburgh, CA) 297-bp region SalI site carboxyl-           plate removed. Radiolabeled Sec31p terminal coding sequence. sequence mutation, genomic se-          visualized Phosphorlmager cut gel. gel
quences amplified PCR region wild-type         slice hydrolyzed 750 ,ul 6 N HCl 1 h 110°C cells (RSY255) sec31-1 cells (RSY1004) using primers generated       removed fresh tube lyophilized. Hydrolyzed amino acids original sequencing SEC31. Genomic DNA pre-            eluted tube washes 100 pLI deionized
pared growing 10 ml yeast minimal medium saturation          H20 (dH20) combined 3 ,ul unlabeled phosphoamino
(approximately 15 OD600 units cells/ml). cells centrifuged      acid standards (1 mg/ml phosphoserine, phosphothreonine, 5 min maximum speed table centrifuge resus-          phosphotyrosine). Amino acids separated residual
pended 0.5 ml H20. cells lysed vortexing            acrylamide binding 1 ml 1:2 (wt/vol) AG1x8 resin (Bio-Rad)
maximum speed 4 min 0.2 ml 2  Triton X-100, 1  SDS, 0.1        3.5 ml dH2O adjusted pH 7.5 200 mM NH40H. Binding
M NaCl, 10 mM Tris-HCl (pH 8.0), 1 mM EDTA, 0.2 ml phenol-               carried overnight room temperature rotation. chloroform (1:1), 0.3 g glass beads (0.5 mm diameter).   resin washed 3 x 0.5 ml dH2O, amino acids addition 0.2 ml 10 mM Tris-HCl (pH 8.0) 1 mM EDTA          eluted 1.2 ml 0.1 N HCl. eluate lyophilized
(TE), aqueous phase removed precipitated 1 ml        resuspended 3 ,ul dH20. resolve phos-
100  ethanol. precipitate collected centrifuging 2        phoamino acids, 2-dimensional layer electrophoresis 20
min 10,000 x g refrigerated microcentrifuge. decanting     cm x 20-cm cellulose plates performed. dimension ethanol solution, pellet dried resuspended 0.4 ml     run 2 h 1000 V pH 1.9 buffer (7.8  acetic acid, 2.5  TE incubated 5 min 37°C 30 ,ug RNase            formic acid). cellulose plate dried completely, second
remove RNA. DNA precipitated addition 5.4 ,ul 7.5       dimension run 45 min 1000 V pH 3.5 buffer (5  acetic
M (NH4)2OAc 1 ml 100  ethanol centrifuged             acid, 0.5  pyridine). Phosphoamino acid standards visualized
10,000 x g 2 min. resulting pellet dried resus-          spraying dried plate 0.1  ninhydrin 95  ethanol. pended 50 ,ul TE, 1 ,ul used PCR amplifica-       radiolabeled phosphoamino acids visualized using tion. Amplification reactions contained 0.2 mM deoxyribo-           Phosphorlmager.
nucleoside triphosphate, 1 ,uM primers, 1 U Taq DNA polymerase, Ix incubation buffer (Boehringer Mannheim). Primer (5'-
GTCCGTATACTAATAA-3') primer 150 (5'-AGCATGGTTT-                    Phosphatase Treatment
GTAGCGATA-3') used amplify 499-bp fragment                Sarlp (0.6 ,ug), Sec23p/Sec24p (1 ,ug), Secl3p/Sec31p (1.4 ,ug)
position 3254-3753. Amplification products sequenced           treated 1 ,ug grade alkaline phosphatase calf finolT DNA sequencing (Promega, Madison, WI) accord-          intestine (Boehringer Mannheim) 0.05 M Tris (pH 8.5) 0.1
ing manufacturer's instructions using primer 150 end-           mM EDTA 30 min 37°C. phosphatase reactions labeled [)y-32P]ATP (3000 Ci/mmol, New England Nuclear).            stopped addition 0.01 volume 200 mM ethylenebis(oxy-
                                                                         ethylenenitrilo)tetraacetic acid (EGTA) incubating 5 min Phosphate Labeling Sec3lp Vivo                                     ice. Budding reactions (25 ,ul) performed using 5 Al                                                                          phosphatase-treated fraction described (Salama et al., 1993), ex-
RSY255 (1.25   OD600 units)   cells inoculated 5 ml low       cept 100 mM GMP-PMP replaced ATP-regenerating phosphate sulfate medium (Reneke et al., 1988) fresh          GTP reaction contained 20 mM EGTA. determine
ovemight culture grown 1 OD600 unit cells/ml 30°C. Cells       inhibition caused addition phosphatase harvested clinical centrifuge 5 min maximum speed       rescued untreated protein fractions, parallel reactions resuspended 2.5 ml low phosphate sulfate medium.           supplemented Sec13p/Sec31p (0.35 ,ug), Sarlp (0.15 ,g), equilibration 10 min 30°C, 0.5 mCi [FP2inorganic         Sec23p/Sec24p (0.5 ,ug).


 208                                                                                                          Molecular Biology Cell
                                                                                                                  SEC31 Characterization

RESULTS                                                                ing frame 1273 codons encoding protein Cloning p150                                                        predicted molecular weight 139 kDa pl                                                                        5.53. open reading frame contains pep- previously demonstrated functional form                    tides sequenced purified protein. Addition- Secl3p purifies heterodimer p150                      ally, sequences 3' untranslated region protein (Salama et al., 1993). clone gene encod-                exact match 5' untranslated region SNF3
ing p150, took advantage observation                    gene. SNF3 gene p150 map left Secl3p/p150 complex dissociated 2 M                    arm chromosome IV (Marshall-Carlson et al., 1990).
urea subunits resolved size exclusion chro-                 sequence reveals potential transmembrane
matography (Figure 1). Interestingly,                  segments signal sequence. homology search 
ditions, p150 fractionates large protein mi-                 ing PROSITE dictionary protein sites pat-
grating ahead thryoglobulin (669 kDa),                  terns (release 10.3) GCG sequence analysis pack-
position native Secl3p complex (Salama et al.,                  age (version 7.3, Genetics Group, ,
1993). analyzed sedimentation glyc-                    Madison, WI) revealed seven WD repeats near erol gradients, Secl3p complex fractionates                   amino terminus protein (Figure 2). carbox- S value 7.8 corresponding 166-kDa protein                yl-terminal half protein rich serine, threo- expected heterodimer containing                      proline residues displays significant
copy subunit.  aberrant migration                  homologies. characterization clone, Secl3p complex gel filtration probably                   discovered gene encoding p150 identical
sults p150 subunit having highly elongated                  WEBI, locus defined single mutation webl-1
structure.                                                             producing cells require viral protein ElA   ability fully resolve p150 Secl3p al-                    growth rich medium (Zieler et al., 1995). DNA
lowed peptide sequencing purified protein. Nei-                 sequence available GenBank accession number
ther amino terminal internal peptides displayed                    U15219 (Zieler et al., 1995).
homology proteins known time. Conse-
quently, degenerate oligonucleotide primers 
signed based amino acid sequence amino                   p150 Encoded Essential Gene Required terminal peptide internal peptides. PCR                 Secretion
amplification yeast genomic DNA using prim-                   determine yeast requires p150 viabil-
ers yielded single product encoding amino ter-                   ity, null allele constructed vitro replacing
minus p150. yeast genomic library screened                    majority coding region  codons 26- probe PCR product isolate                   1174) prototrophic marker TRP1 LEU2 length clone. Sequencing initiated flank-                (Figure 2C). alleles integrated ing vector sequences revealed amino terminus                  chromosomes diploid wild-type cell p150 fell 100 bp vector insert junction.              sporulated. Dissection independent
Sequencing 3' direction revealed open read-
                                                                            Kpn 1             Xho    Spe        Sal            M L 16 18 20 22 24 26 28 30 32 34 36 38 40                        78               1707     2446         3522 Xho                                                                                                        l
                                                                                                                         404
200 -      _
150 -          -              _
                                  dim                                       1                                         3819

  93 -
  68 -     -
                                                                       -4                    TRP1 /LEU2
                                                                                                                                  Growth
                                                                                                                                   ' 380C


  46   -                                                                                                                           +




Figure 1. Secl3p complex sensitive 2 M urea. Purified
Secl3-dhfrp/pl50 complex (0.7 mg, 1 ml) diluted 1:1 2x urea     Figure 2. Cloning p150. Schematic representation p150/
buffer (4 M urea, 0.4 M NaCl, 0.25 M Tris-HCl, pH 7.5) dissociate   SEC31 locus pNS3132 growth phenotype derivative Secl3p complex loaded 104-ml Superose 6 column          plasmids 38°C. position restriction sites used equilibrated 1 x urea buffer. Fractions (2 ml) collected   insertion TRP1 LEU2 sequences construction null
analyzed SDS-PAGE followed silver staining visualize      allele mapping sec31-1 mutation indicated. proteins. position molecular weight markers (M) kDa;     WD-motif S,T,P-rich region indicated  text 
load (L) fraction numbers indicated.                           tails).

Vol. 8, February 1997                                                                                                                209
 N.R. Salama et al.

integrants yielded tetrads (12  displaying                     3C). Exaggerated ER structures characteristic living spores auxotrophic leucine tryptophan                     class ER Golgi sec mutants defective dead spores cases, showing p150                       vesicle formation (Kaiser Schekman, 1990).
required cell viability.
  address role p150 secretion, placed gene control GALl promoter.                       p150 Allelic SEC31
promoter drives transcription galactose used                    SEC31 gene identified screen new carbon source represses transcription                     temperature-sensitive (ts) mutants defective cells grown glucose-containing medium.                       processing yeast mating pheromone, factor
GALl:p150 gene plasmid containing LEU2                         (Wuestehube et al., 1996). restrictive tempera-
gene introduced diploid cells heterozygous                     ture 38°C, sec31-1 cells accumulate ER precursor pl50::TRP1 null allele. Transformants                      forms secretory proteins, extended ER
sporulated Leu+ Trp+ spores selected galac-                      membranes, small transport vesicles.
tose-containing minimal media. cells grown                     phenotypes suggest SEC31 gene prod- galactose shifted glucose-containing                     uct functions vesicle formation ER. medium. Figure 3A shows cells shifted glucose                   limited screen low copy suppressors sec31-1
stop growing 8-10 h. Transport vacuolar                    ts growth defect led isolation single plasmid
protease CPY monitored 0, 2, 6, 8 h                    (named 32H1) completely restored growth shifting glucose. CPY synthesized precursor                  38°C. time, tested individually core glycosylated entry                      ability known SEC genes, contained low
ER, yielding pl form. Entry Golgi results                  copy (CEN) plasmids, suppress sec31-1 growth elaboration carbohydrate structure, causing                 defect. SEC24 showed weak suppression shift electrophoretic mobility p2 form.                  ts growth phenotype, plasmid containing transported vacuole, pro-sequence cleavage oc-                   gene encoding p150 suppressed sec31-1 completely.
curs, yielding mature (m) active protease.                       Subsequent restriction analysis DNA blot hybrid-
shown Figure 3B, 0- 2-h time points                       ization revealed p150 gene 32H1 overlap
pulse-labeled CPY matured normal rate. 6 h                      sequence.  low doses, p150 gene sup- shift glucose,  secretion block                  pressed Ts- growth secretion phenotypes developed CPY accumulated ER indi-                        sec31-1.
cated persistence pl form                    test identity p150 gene SEC31, chase. block secretion preceded cessation                pl50::LEU2 null allele integrated sec31-1/
cell division 2-4 h. Ultrastructural analysis showed                 SEC31 heterozygous diploid. Leu+ integrants block secretion caused p150 depletion                    expected genomic structure determined led elaboration ER membranes (Figure                      DNA blot hybridization analysis. integrants

              RSY1076 Growth Curve                                   B             Time (hr) shift glucose
                                                                                          0     2     6      8
                                                                                              m          m             F           m
                                                                                          0       15 0       15 0           15 0       15   chase (min)
                                                                         p2(Golgi) \
                                                    0      glucose          pl(ER)-      -^          -   V
                                                                                                                 *,.        w.
                                                                                                                           e,      ...

                                                                                                             4

 0                                                  °      galactose   m(vacuole)




                         Time (h)
Figure 3. p150 depletion vivo.   Growth curve RSY1076 (pHZ134 (GALI:p150, LEU2, ARS1, CEN4) pl50::TRPI) grown glucose- galactose-containing media. (B) Secretion phenotype 0, 2, 6, 8 h shift glucose. Cells pulse radiolabeled 5 min
followed 0- 15-min chase immunoprecipitated anti-CPY antiserum. pulse labeling, ER form CPY (pl)
predominates. 15-min chase beginning Sec31p depletion (0 h), CPY Golgi modified form (p2) arrived vacuole cleaved mature form (m). Cells begin display transport defect 6 h shift glucose. (C)
Electron micrographs GAL1:pl50 cells (RSY1076) 0 6 h shift glucose. Bar, 1 ,.m.


210                                                                                                                        Molecular Biology Cell
                                            SEC31 Characterization


c




        6h
                        Figure 3 (cont).




Vol. 8, February 1997                                         211
 N.R. Salama et al.
 tested ability grow 38°C. integrants Ts- growth.                            sec allele
p150::LEU2 sec31-1 fail complement. 
maining Ts+ integrants presumed result
                                                                    wt 16-2 23-1                  plasmid replacement sec31-1 sequence (instead wild-type SEC31 sequence) p150::LEU2                                                 vector
sequence.
  Ts- diploids (relevant genotype,
sec31-1/p150::LEU2) sporulated, meiotic
products separated micromanipulation. Anal-
ysis 32 tetrads revealed 29 segregated Ts-: dead spores Ts- spores Leu-.                                              SEC31 remaininf tetrads, tetrad segregated Ts- Ts: dead; viable spores recombinant tetrad Leu-. remaining tetrads segregated Ts-: dead. tetrads presumed products gene                                               SEC13, SEC31
version events, Ts- spores Leu-. simultaneous conversions Leu+ Leu- Ts+ Ts-, addition low level recom-     Figure 4. High copy expression SEC31 inhibits growth bination lack complementation            secl6-2 sec23-1 strains. indicated plasmids, YEp352 (vector:
p150::LEU2 sec31-1, strongly suggest       URA3, 2,t), pNS3132 (SEC31: SEC31, URA3, 2,u), pNS3113
mutations allelic.                                      (SEC13, SEC31: SEC13, SEC31, URA3, 2t,) transformed                                                             RSY255 (wild type), RSY267 (secl6-2), RSY281 (sec23-1). Single
                                                            transformants selected minimal medium lacking uracil                                                             restreaked. Single colonies resuspended 100 ,ul sterile
SEC31 Overexpression Synthetically Lethal           H20, replica plated minimal medium plate lacking uracil,
sec23-1 secl6-2                                         grown 3 d 30'C.
Protein-protein interactions reflected pattern suppression mutations plasmids 
coding subunits complex. checked            wild-type sec31-1 cells shifted 1 h 38°C, high copy expression SEC31 suppress ts         nonpermissive temperature sec31-1 (Wuestehube
growth ER Golgi mutants. SEC31          et al., 1996). Complex formation measured
gene high copy did suppress SEC           using size exclusion chromatography. Figure 5 shows
genes tested, did lower restrictive temperature     profile Secl3p Sec3lp immunoreactivity secl6 -2 sec23-1. data Figure 4     Superose 6 gel filtration column loaded 30°C, restrictive temperature      cytosol prepared wild-type strain   mutations, cells containing plasmid       sec31-1 strain (B). wild-type cytosol, Secl3p frac-
vector grew cells containing SEC31 gene insert      tionated high molecular weight form did  toxicity specific alleles   apparently monomeric form, analogous results sec23 secl6 alleles did       previously reported cells grown 30°C,  growth inhibition temperature         mal growth temperature (Pryer et al., 1993). Unfortu-
restrictive temperature. Interestingly, cells containing    nately, instability wild-type Sec3lp vitro high copy plasmid encoding SEC13 SEC31 genes grew temperature. Overproduc-           (Salama et al., 1993) quantitation protein
tion SEC13 toxic Ts- strains.     fractions inconsistent. Secl3p, contrast, results indicate monomeric Sec3lp,       quite stable. sec31-1 cytosol,  Sec31p complexed Secl3p monomeric Secl3p,           Secl3p fractionated position mono- toxic cells compromised ER Golgi       meric protein. Quantitation '25I-labeled protein transport.                                                  bound filters using PhosphorImager (Mo-
                                                            lecular Dynamics) revealed shift complex                                                             monomer ratio 4.5 wild-type cytosol 0.25 Sec31-lp Defective Association Secl3p           sec31-1 cytosol. ratio Sec3lp Secl3p Secl3p functions vesicle formation form      load fractions similar. heterooligomeric complex Sec3lp (Pryer et         exclude possibility Sec31-lp al., 1993; Salama et al., 1993). prompted        somewhat stable wild-type protein, determine Sec31-1p engage Secl3p           appears major effect weaker interaction complex. test  prepared cytosol      mutant protein Secl3p.

212                                                                                              Molecular Biology Cell
                                                                                                                     SEC31 Characterization


                        SEC3J                                                             sec3l-J
                    c                        m                                        c                       m
                  m                      m                                      m                       m        L 182022242628303234363840                                       L 182022242628303234363840
    _"
                                                                                                                               Sec3lp

                                                                                 m    Ann*-




                                                                                                                               Secl3p
                        compe x                                           Sec 3p "Conpl'C
               Slpmonom~er-45                                                      m~onomer = 0.25
Figure 5. Sec3l-lp defective association Secl3p. aliquot (200 dL) wild-type (SEC31, 28 mg protein/ml) sec3l-1 (14 mg protein/ml) temperature-shifted cytosol loaded 24-ml Superose 6 column equilibrated B88 0.5 mM PMSF using Pharmacia FPLC  Fractions collected (0.5 ml) aliquots (10 ,lI) analyzed SDS-PAGE followed transfer nitrocellulose.
Immunoblots probed affinity-purified anti-Secl3p antibodies (1:1000) developed enhanced chemiluminescence
detection (Amersham). fraction numbers indicated. c, position Sec13p complex; L, load fraction; m, position Secl3p
monomer. determine ratio Secl3p complex monomer, immunoblots incubated 1251I-labeled protein exposed Phosphorlmager cassette (Molecular Dynamics). radioactivity present arbitrary units complex fractions
(22-26) divided present monomer fractions (34-38).


  mapped sec31-1 mutation using gap repair                       number unstable proteins, phos-
(Orr-Weaver et al., 1983). technique relies                     phorylation proteins play role ability yeast repair gapped plasmids                     degradation (Rogers et al., 1986). checked chromosomal sequences transformation.                         stability Sec3lp pulse chase analysis, gapped region does include mutation,                        quite stable course 60-min chase.
repair result plasmid containing wild-                      examined phosphorylation Sec3lp.
type copy gene complement ts                        Cells labeled [ 2P]inorganic phosphate fol-
growth phenotype. missing sequence includes                      lowed immunoprecipitation anti-Sec3lp anti- mutation, repaired plasmid include                    serum. data Figure 6 Sec31p mutation resulting strain grow                     labeled 32p; phosphoaminoacid analysis nonpermissive temperature. shown Fig-                      immunoprecipitated protein revealed phos-
ure 2, sec31-1 mutation maps 3' coding                       phate occurs serine residues. Phosphoaminoacid
region SailI site end gene.                  analysis Sec3lp immunoprecipitated sec31-1
Using PCR, amplified portion gene                        secl3-1 cells yielded identical pattern. genomic DNA prepared sec31-1 wild-type haploid cells. Direct sequencing                       Phosphorylation Sec3lp Important Vesicle
PCR products revealed missense mutation C                        Formation Activity T position 3716, changing valine 1239 ala-                     biochemical reaction reconstituting vesicle forma-  results suggest C-                         tion ER vitro requires cytosolic pro-
terminus Sec3lp involved contact                      teins: Sarlp, Sec23/24p complex, Secl3/31p com-
Secl3p form complex.                                             plex (Salama et al., 1993). developed means                                                                         test phosphorylation Sec3lp impor-
Sec3lp Phosphoprotein                                              tant vesicle formation. treated analyzing protein sequence Sec3lp,                       fractions required promote vesicle formation noted carboxyl-terminal half contains                    phosphatase measured vesicle formation ac-
usually high occurrence serine, threonine, pro-                  tivity using mixtures containing treated line residues. residues make PEST motif                      untreated proteins. shown Figure 7, 
Vol. 8, February 1997                                                                                                                   213
 N.R. Salama et al.

          M                1        2
                                                                                     30 -

                                                                                     25 -

200                      MI.    ..                                                   20 -
                     .                                                               15 -

                                  .',x
                                Se3
                               *>                                                    10 -

                                                                                      5-

97.4                                                                                  0
                                                                                          Secl3p/Sec3lp      Sarlp     Sec23p/Sec24p
                                                                                                          Fraction
  69                                     Figure 6. Sec3lp phos-
                                         phoprotein. Immunoprecipi-                         E    Phosphatase treated
                                         tations using anti-Sec31p
                                         antiserum (lane 2) preim-                            Phosphatase treated + untreated
                                         mune serum (lane 1) cell
                                         lysates radiolabeled vivo   Figure 7. Phosphatase treatment inhibits ability Sec3lp-
                                         [32P]inorganic phos-      containing fraction promote vesicle formation. Sarlp (0.6 ,ug),
                                         phate analyzed         Sec23p/Sec24p (1 j,g), Secl3p/Sec3lp (1.4 jig) treated                                          SDS-PAGE visualized        1 ,ug grade alkaline phosphatase (Boehringer Mannheim) 0.05
  46                                     using Phosphorlmager         M Tris (pH 8.5) 0.1 mM EDTA incubated 30 min 37°C.
                                         (Molecular Dynamics).      phosphatase reactions stopped addition 0.01
                                         position molecular weight   volume 200 mM EGTA incubated 5 min ice. Budding
                                         markers (lane M) kDa     reactions (25 pl) performed using 5 Al phosphatase-
                                         indicated.                     treated fraction described  100 LiM GMP-PNP 
                                                                        placed ATP-regenerating GTP reaction
                                                                        contained 20 mM EGTA (hatched bars). determine                                                                         inhibition caused addition phosphatase overcome
Sarlp Sec23/24p complex sensitive                        untreated protein fractions, parallel reactions supple-
phosphatase treatment. contrast, phosphatase                         mented Secl3p/Sec3lp (0.35 ,ug), Sarlp (0.15 ,g), Sec23p/
                                                                        Sec24p (0.5 ,ug; filled bars).
treatment Secl3/31p complex inhibited vesi-
cle formation 50 . addition untreated
Secl3/31p complex overcame inhibition. Phos-                       DISCUSSION
phatase treatment immunoprecipitated protein radiolabeled yeast cells conditions                    COPII vesicle coat protein contains protein
resulted removal 90  phos-                       subunits: Sarlp, Sec23p, Sec24p, Secl3p, p150
phate Sec3lp SDS-PAGE analysis                          (Barlowe et al., 1994).  report p150
Secl3/31p fraction phosphatase treatment                          protein encoded SEC31 gene essen-
showed protein degraded.                       tial yeast cell viability. Sec31p/p150 depletion Secl3/31p complex essential vesicle                      vivo results secretion block ER mation activity, considered possibility                     Golgi elaboration ER membranes. phosphatase treatment disrupted Secl3/31p                           phenotype characteristic class ER Golgi sec
                                                                        mutants (Kaiser Schekman, 1990) include
complex.  size exclusion chromatography                         SEC13 SEC23, subunits COPII. SEC31
showed Secl3/31p complex remained intact                       identified genetic screen mutants accu- phosphatase treatment. direct comparison                     mulating unprocessed forms yeast secretory
radiolabeled immunoprecipitated Secl3p                          protein factor (Wuestehube et al., 1996). Sec3lp showed phosphorus label Sec3lp,                          sec31-1 mutant nonpermissive temperature conclude phosphorylation                       depletion wild-type protein cause disruption subunit COPII coat required activity                 ER Golgi transport. contrast depleted transport vesicle formation.                                         strain, Sec31-1 mutant protein persists cells incu-

214                                                                                                          Molecular Biology Cell
                                                                                                 SEC31 Characterization

bated restrictive temperature.  mu-        Coat subunits bind directly proteins desig-
tant protein defective recruitment Secl3p   nated transport. 13' subunit, heterooligomeric complex. monomeric Secl3p          combination E subunit appear interact unable promote vesicle formation, mutant          directly di-lysine retention motif defect relate lack Secl3/31p complex       ER resident transmembrane proteins (Cosson monomeric Sec3lp toxic cells. Addi-           Letourneur, 1994; Letourneur et al., 1994). tional insight phenotype sec31-1 strain     led model COPI recruits escaped di- come observation overproduction           lysine bearing proteins retrograde transport ves- wild-type Sec3lp, Secl3/31p complex       icles Golgi delivery ER. Secl3p, lowers restrictive temperature        time known cargo molecules  different ER Golgi mutants, sec23-1 secl6-2.     cruited COPII vesicles. Morphological analysis strains appears specific toxicity    secretory proteins vivo demonstrated se-
resulting overexpression monomeric Sec3lp.          cretory cargo concentrated transport vesicles ex-
Alternatively, proteins physically         iting ER (Mizuno Singer, 1993; Balch et al.,
associated Sec3lp vivo, overexpression       1994). ER-derived transport vesicles formed using
Sec3lp mutant cells alter effective concen-      COPII vitro exclude ER resident proteins 
tration crippled proteins. SEC23 encodes        clude vesicle resident proteins (Salama et al., 1993; subunit COPII, Secl6p associ-         Barlowe et al., 1994; Rexach et al., 1994). Secl3p/
ated ER-derived transport vesicles (Espenshrade        Sec3lp complex couple recruitment cargo et al., 1995). SEC16 encodes 240-kDa cytosolic protein    vesicle formation, serve purely structural associated Sec23p required          role vesicle morphogenesis.
vesicle formation vivo. Secl6p tightly      SEC31 independently defined gene, WEBI,
bound ER membrane,           mutant allele confers dependence possible develop assay detect requirement        adenovirus transcription factor ElA yeast cell protein vitro budding reaction.      growth (Zeiler et al., 1995) single mutant allele,
sequence Secl6p contains large region predicted        webl-1, changes D189, conserved residue form coiled coils consistent structural        WD repeats, N. Cells harboring mutation scaffolding function, helping organize       display secretory defect incubated COPII coat.                                                 nonpermissive temperature mutant protein
   predicted amino acid sequence Sec3lp gives        associates Secl3p normally. connection  obvious clues biochemical activity vesicle     tween ElA phenotype vesicle budding formation. Sec3lp contains seven WD repeats, repeat       ER obscure.
motif Secl3p. sequence, originally         shown phosphorylation serine res-
characterized 1B subunit heterotrimeric G         idues Sec3lp promotes transport vesicle formation
proteins, does known function. Proteins        vitro. Phosphorylation/dephosphorylation bearing WD repeats participate variety cellular     Sec3lp provide mechanism regulation processes, including transcriptional activation, RNA        membrane traffic. Unfortunately, physiological splicing, spindle pole body formation.         cell cycle control protein transport ER ingly, COPI, coat protein operates        known yeast. Alternatively, kinase/phosphatase
tween ER Golgi, contains sub-          cycle promote assembly/disassembly units WD repeats: 13'. subunit (160        coat structure round vesicle budding.
kDa) 13' subunit (102 kDa) encode large        phosphorylation necessary main-
proteins WD repeats confined amino          tain Secl3/31p complex, lateral association terminus case Sec3lp.  amino-      COPII coat require phosphorylated form terminal deletion removes WD repeats        Sec3lp. Conversely, phosphatase located ves- subunit partially complements growth pheno-           icle surface activated completion type ts mutation gene (Letourneur et al.,      budding cycle dephosphorylate Sec3lp loosen
1994), motif serve redundant function.      coat, allowing individual complexes shed
   WD repeats play role lateral orga-      membrane. model predicts role nization coat protomers COPI COPII vesi-          nucleotide  likely ATP) hydrolysis mediated cles. Interestingly, ts alleles SEC13 map   kinase vesicle budding;  require-
conserved residues WD repeats (Pryer, et al.         ment seen budding reaction reconstituted
1993), strains accumulate mono-           purified proteins.  absolute nu-
meric Secl3p (Yoshihisa, unpublished results).          cleotide requirement GTP, nonhydrolyz-
sec31-1 mutation maps outside repeats,     able analogue (GMPPNP) suffices. putative ki- likely WD repeats involved        nase acts cytosolic Sec3lp, pool Secl3/31p
protomer (coatomer Secl3p/Sec3lp) structure.             isolated yeast lysate used reconstituted

Vol. 8, February 1997                                                                                              215
 N.R. Salama et al.

budding reaction active phos-                      Jones, J.S., Prakash, L. (1990). Yeast Saccharomyces cerevisiae
phorylated state. circumstance, ATP                      selectable markers pUC18 polylinkers. Yeast 6, 363-366.
kinase necessary single round                        Kaiser, C., Schekman, R. (1990). Distinct sets SEC genes
vesicle budding. requirement relevant                       govern transport vesicle formation fusion early secretory
kinase detected using unphosphorylated                            pathway. Cell 61, 723-733.
Secl3/31p complex.                                                       Laemmli, U.K. (1970). Cleavage structural proteins                                                                          assembly head bacteriophage T4. Nature 227, 680-685.
                                                                         Letourneur, F., Gaynor, E.C., Hennecke, S., Demoliere, C., Duden,
ACKNOWLEDGMENTS                                                          R., Emr, S.D., Riezman, H., Cosson, P. (1994). Coatomer thank Arie Ademon performing peptide sequencing            essential retrieval dilysine-tagged proteins ER. Cell 79,
p150, Helge Zieler providing plasmid pHZ134 sharing              1199-1207.
results prior publication, Susan Hamamoto preparing electron      Malhotra, V., Serafini, T., Orci, L., Shepherd, J.C., Rothman, J.E.
micrographs, Laura England Steve Martin help phos-          (1989). Purification novel class coated vesicles mediating
phoamino acid analysis, finally members Schekman          biosynthetic protein transport Golgi stack. Cell 58,
lab advice encouragement. acknowledge funding              329-336.
N.R.S. National Science Foundation predoctoral fellowship,       Marshall-Carlson, L., Celenza, J.L., Laurent, B.C., Carlson, M.
J.S.C. Howard Hughes Medical Institute predoctoral fellow-        (1990). Mutational analysis SNF3 glucose transporter Sac-
ship, R.W.S. Howard Hughes Medical Institute.              charomyces cerevisiae. Mol. Cell. Biol. 10, 1105-1115.
                                                                         Mizuno, M., Singer, S.J. (1993). soluble secretory protein REFERENCES                                                               concentrated endoplasmic reticulum transfer Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seidman, J.G.,    Golgi apparatus. Proc. Natl. Acad. Sci. USA 90, 5732-5736.
Smith, J , Struhl, K. (eds.) (1987). Current Protocols Molec-   Nakano, , Brada, D., Schekman, R. (1988). membrane
ular Biology. Boston, MA: Harvard Medical School.                        glycoprotein, Secl2p, required protein transport endo-
Balch, W.E., McCaffery, J.M., Plutner, H., Farquhar, M.G. (1994).    plasmic reticulum Golgi apparatus yeast. J. Cell Biol. 107,
Vesicular stomatitis virus glycoprotein sorted concentrated       851-863. export endoplasmic reticulum. Cell 76, 841-852.          Neer, E.J., Schmedt, C.J., Nambudripad, R., Smith, T.F. (1994).
Barlowe, C., Orci, L., Yeung, T., Hosobuchi, M., Hamamoto, S.,           ancient regulatory-protein family WD-repeat proteins. Na-
Salama, N., Rexach, M.F., Ravazzola, B., Amherdt, M., Schek-         ture 371, 297-300.
man, R. (1994). COPII: membrane coat formed Sec proteins       Orci, L., Palmer, D., Amherdt, M., Rothman, J.E. (1993). Coated
drive vesicle budding endoplasmic reticulum. Cell 77,           vesicle assembly Golgi requires coatomer ARF
895-907.                                                                 proteins cytosol. Nature 364, 732-734.
Barlowe, C., Schekman, R. (1993). SEC12 encodes guanine-           Orr-Weaver, T.L., Szostak, J.W., Rothstein, R.J. (1983). Genetic
nucleotide-exchange factor essential transport vesicle budding       applications yeast transformation linear gapped plas- ER. Nature 365, 347-349.                                        mids. Methods Enzymol. 101, 228-245.
Bednarak, S., Ravazzola, M., Hosobuchi, M., Amherdt, M., Perrelet,       Palade, G. (1975). Intracellular aspects process protein , Schekman, R., Orci, L. (1995). COPI- COPII-coated            secretion. Science 189, 347-358.
vesicles bud directly endoplasmic reticulum yeast. Cell      Pepperkok, R., Scheel, J., Horstmann, H., Hauri, H.P., Griffiths, G.,
83, 1183-1196.                                                           Kreis, T.E. (1993). ,3-COP essential biosynthetic membrane
Cosson, P., Letourneur, F. (1994). Coatomer interaction         transport endoplasmic reticulum Golgi complex di-lysine endoplasmic reticulum retention motifs. Science 263,           vivo. Cell 74, 71-82.
1629-1631.                                                               Peter, F., Plutner, H., Zhy, H., Kreis, T.E., Balch, W.E. (1993).
d'Enfert, C., Wuestehube, L.J., Lila, T., Schekman, R. (1991).       ,B-COP essential transport protein endoplasmic
Secl2p-dependent membrane binding small GTP-binding               reticulum Golgi vitro. J. Cell Biol. 122, 1155-1167.
protein Sarlp promotes formation transport vesicles ER.      Pryer, N.K., Salama, N.R., Schekman, R.W., Kaiser, C  (1993).
J. Cell Biol. 11, 663-670.                                               Cytosolic Secl3p complex required vesicle formation Elble, R. (1992). simple efficient procedure transformation    endoplasmic reticulum vitro. J. Cell Biol. 120, 867-875. yeasts. Biotechniques 13, 18-20.                                      Reneke, J.E., Blumer, K.J., Courchesne, W.E., Thorner, J. (1988).
Espenshade, P., Gimeno, R., Holzmacher, E., Teung, P., Kaiser,       carboxy-terminal segment yeast factor receptor C. (1995). Yeast SEC16 gene encodes multidomain vesicle coat           regulatory domain. Cell 55, 221-234.
protein interacts Sec23p. J. Cell Biol. 131, 324-338.          Rexach, M.F., Latterich, M., Schekman, R.W. (1994). Character-
Guthrie, C., Fink, G.R. (1991). Guide yeast genetics          istics endoplasmic reticulum-derived transport vesicles. J. Cell
molecular biology. Methds Enzymol. 194, 169-272.                         Biol. 126, 1133-1148.
Harlow, E., Lane, D. (1988). Antibodies: Laboratory Manual.        Rexach, M.F., Schekman, R. (1991). Distinct biochemical 
Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press.             quirements budding, targeting fusion ER-derived
Hicke, L., Yoshihisa, T., Schekman, R. (1992). Sec23p          transport vesicles. J. Cell Biol. 114, 219-229.
novel 105-KDa protein function multimeric complex promote        Rogers, S., Wells, R., Rechsteiner, M. (1986). Amino acid se-
vesicle budding protein transport endoplasmic retic-        quences common rapidly degraded proteins: pest hypothesis.
ulum. Mol. Biol. Cell 3, 667-676.                                        Science 234, 364-368.
Hill, J.E., Myers, M., Koerner, T.J., Tzagoloff,  (1986).        Salama, N.R., Yeung, T., Schekman, R.W. (1993). Secl3p
Yeast/E. coli shuttle vectors multiple unique restriction sites.    complex reconstitution vesicle budding ER Yeast 2, 163-167.                                                        purified cytosolic proteins. EMBO J. 12, 4073-4082.

216                                                                                                             Molecular Biology Cell
                                                                                                                       SEC31 Characterization

Sambrook, J., Frisch, E.F., Maniatis, T. (1989). Molecular Clon-      sheets: procedure applications. Proc. Natl. Acad. Sci. USA
ing: Laboratory Manual. Cold Spring Harbor, NY: Cold Spring             76, 4350-4353.
Harbor Labor